McKesson Corporation (MCK) Stock Analysis — Probabli.AI
AI-powered analysis for MCK (McKesson Corporation): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. AI consensus: Bullish.
Last price: $754.76 · Market cap: $92.5B · AI consensus: Bullish
McKesson Corporation has strong growth potential, supported by its leadership in pharmaceutical distribution and its strategic initiatives in digital health and sustainability. Despite facing challenges such as lawsuits and supply chain issues, the company's solid fundamentals and positive industry outlook suggest above-market returns over medium-to-long-term timeframes.
Probabilistic 1-Year Outlook
- Bull 4500% · Neutral 3500% · Bear 2000%
- McKesson Corporation is in a good position for growth given its recent acquisition and telehealth initiatives. However, supply chain issues and legal disputes create downside risks.
5-Year Outlook
- Bull 5000% · Neutral 3000% · Bear 2000%
SWOT Highlights
- Strength: Market leader in pharmaceutical distribution
- Strength: Strong financial performance with consistent earnings growth
- Risk: Low dividend yield
- Risk: Supply chain vulnerabilities
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
14 Wall Street analysts rate MCK a BUY with a mean price target of $952.92. McKesson Corporation currently pays a dividend with a yield of approximately 0.43%.
Analysis generated May 7, 2026 · Model: gpt-4o. Run a fresh analysis on probabli.xyz/stock/MCK.
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.